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Abstract  
Biological properties of Sphaeralcea angustifolia have recently attracted attention because of the potential that this Mexican medicinal plant has as a remedy 
to treat inflammation. The dichloromethane extract of the plant’s aerial parts inhibits pro-inflammatory molecules such as Interleukin (IL)-1, Tumor necrosis 
factor (TNF)- , and IL-6 with a maximum expression in the late phase, an effect that is consistent with the findings in the present study, which showed that in 
rats with induced chronic inflammation by means of Complete Freund’s adjuvant (CFA), the extract (100 mg/kg per day for 8 days) produced a sustained and 
significant inhibition of the edema (62.6%). Topical application of the dichloromethane extract produced ear edema reduction (50.6%) and a protective effect 
against 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced mouse ear irritation. Active fractions contain -sitosterol, stigmasterol, - and -amyrins, 
transcinnamic acid, and scopoletin, with scopoletin the main constituent found in the more active fraction of the extract. The results obtained here 
demonstrated both the systemic and topic effects of S. angustifolia on experimental chronic-inflammation models with no evidence of toxic effects of the 
extract. 
 
Keywords:  Sphaeralcea angustifolia, scopoletin, Freund’s adjuvant-induced arthritis, anti-inflammatory plant. 
 
Resumen 
Las propiedades biológicas de Sphaeralcea angustifolia han atraído recientemente la atención debido al potencial de esta planta medicinal mexicana como 
remedio para tratar la inflamación. El extracto de diclorometano de las partes aéreas inhibe moléculas pro-inflamatorias como la IL-1, TNF-  e IL-6 con una 
máxima expresión en la fase tardía, este efecto es consistente con los hallazgos del presente estudio que mostró que en ratas con inflamación crónica inducida 
con adyuvante de Freund completo, la administración del extracto (100 mg / kg por día por 8 días) produjo una inhibición sostenida y significativa del edema 
(62.6%).  
La aplicación tópica del extracto de diclorometano produjo reducción del edema (50.6%) y un efecto protector contra la irritación producida por TPA en la 
oreja del ratón. Las fracciones activas contienen -sitosterol, estigmasterol, - y - amirinas, ácido trans-cinámico y escopoletina, siendo escopoletina el 
componente principal en la fracción más activa del extracto. Los resultados obtenidos demostraron tanto efectos sistémicos como tópicos de S. angustifolia en 
modelos experimentales de inflamación crónica.  
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INTRODUCTION 
The genus Sphaeralceae (Malvaceae) contains about 
40 species found mainly in western North America, 
with > 50% of these distributed in Mexico. Some of 
these species are used in traditional medicine 
practices. Navajo Indians, for example, the leaves of 
Sphaeralcea coccinea are utilized in lotions to relieve 
skin diseases, or the fresh mashed leaves are employed 
as poultices on inflamed skin, sores and wounds 
(Wyman and Stuart, 1941). In Mexico, the 
representative medicinal species of the genus is 
Sphaeralcea angustifolia Cav. G. Don., a plant 
commonly known as yerba del negro, vara de San 
José, or tlixihuitl in the Nahuatl language, which is 
used as an anti-inflammatory and wound-healing 
remedy. According to ethnobotanical information, the 
fresh plant is topically applied as a poultice that covers 
the affected tissue; sometimes, dietary oil is added to 
the plant. Also, the decoction of the aerial parts of S. 
angustifolia in combination with other medicinal 
species is administered orally for the treatment of 
stomachache and diarrhea and the root has been 
reported for treating bladder disorders (Aguilar et al., 
1994). 
The anti-inflammatory effect of the 
chloroform extract was reported in a preliminary 
screening study in which some plant extracts were 
tested for acute inflammation response (Meckes et al., 
2004). Later, it was demonstrated that in rat adjuvant-
induced arthritis model, intraperitoneal (i.p.) 
administration of the dichloromethane (CH2Cl2) 
extract produced significant inhibition of Interleukin 
(IL)-1 , IL-6, and Tumor necrosis factor (TNF)-  and 
increased levels of the anti-inflammatory IL-10. These 
cytokines showed maximum expression in the late 
phase of the inflammatory process (from day 12 on) 
(Juárez-Ciriaco et al., 2008).  
As part of ongoing research into the 
therapeutic potential of S. angustifolia, the present 
study was undertaken to evaluate the effect produced 
by repeated doses of the CH2Cl2 extract of the aerial 
parts of the plant on induced chronic-inflammation 
response (rat paw edema with complete Freund’s 
adjuvant and ear edema induced topically with 
multiples doses of 12-O-tetradecanoyl phorbol-13-
acetate [TPA] in mouse). Likewise, phytochemical 
analysis of the extract was carried out to identify the 
active principles, responsible for the anti-inflammatory 
effect. 
Taking into account that to our knowledge no 
scientific reports on the toxicity of this plant are 
available, evaluation of acute and sub-acute toxic 
parameters in rodents was undertaken. Because the 
topic application of the plant is frequently employed, 
dermal toxicity of the crude extract was also assayed.  
 
MATERIALS AND METHODS 
Plant material 
S. angustifolia (Cav.) G. Don was collected in the 
State of Hidalgo, Mexico, and was botanically 
identified by Abigail Aguilar, M.Sc. A voucher 
specimen was deposited at the Mexican Institute of 
Social Security Herbarium (IMSSM) with code 
number 14294. A CH2Cl2 extract was obtained by 
macerating the dried aerial parts of the plant (3 kg) at 
room temperature after these had been previously 
defatted with hexane. The extract was concentrated at 
reduced pressure to obtain 30.6 g of a solid extract 
(1.02%). 
 
Experimental animals 
Male Sprague Dawley rats (body weight, 200 - 225 g) 
bred under conventional conditions (21 ± 1° C, 50 - 
70% humidity, sterilized bed), fed with Purina pellets 
and with sterilized water to drink were used. Housing 
conditions and all in vivo experiments complied with 
the guidelines established by the local Ethics 
Committee for Experimentation in Animals in Mexico 
(Ministry of Agriculture, NOM-062-ZOO-1999, 
Mexico), modified in 2001, and were approved by the 
Institutional Animal Care and Use Committee. 
 
Adjuvant-induced chronic inflammation in rats 
Adjuvant polyarthritis was induced as described by 
Andersen (Andersen et al., 2004). Briefly, eight 
animals per group were injected with 0.1 mL of 
Complete Freund´s adjuvant (CFA, heat-killed 
Mycobacterium tuberculosis; Sigma F-5881) in one of 
each of the animals’ hind paws.  
Twelve days after inoculation with CFA, the 
animals were treated with the extract for 8 consecutive 
days (daily doses of 1 g/kg oral administration or 100 
mg/kg intraperitoneal administration). Oral doses were 
administered intragastric twice daily, while when 
administered intraperitoneally (i.p.), the animals were 
injected with the extract only once. Control groups 
included CFA-injected animals that received the 
vehicle H2O:Tween 80 (9:1). Progression of the 
inflammatory response in control groups and the effect 
produced in those receiving the plant extract was 
followed by measuring the ensuing edema with a 
plethysmometer (model 7140; Ugo Basile). In a 
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subsequent experimental study, the effect of the plant 
product was evaluated in the early phase of the 
inflammatory process by administering the extract 
(100 mg/kg i.p.) immediately prior to the sole injection 
of CFA, followed by eight daily treatments. Edema 
was measured 3 h after extract or after vehicle 
administration, and the percentage of inhibition was 
calculated with the following equation (Araruna and 
Carlos, 2010; Chaitanya et al., 2010): 
 
 
 
where ∆vc is the increase in paw volume in the control 
group and ∆vt is the increase in paw volume in 
animals treated with the extract. Edema formation in 
all cases was obtained respect to the paw volume 
measured at initial time T0, before the application of 
carrageenan. 
At the same time, Body weight (BW) in a 
group of animals injected with the adjuvant was 
monitored throughout the period and compared with 
that of a control group of normal animals injected with 
0.1 mL of saline solution.    
 
Mouse ear edema induced by multiple topical 
applications of 12-O-tetradecanoyl phorbol-13-
acetate (TPA) 
Male BALB-c mice (BW, 20–22 g, five animals per 
group) were used. According to Stanley (Stanley et al., 
1991), edema was induced in the left ear by topical 
application of 2.5 µg of TPA dissolved in acetone for 
5 alternate days. The extract (2 mg/ear) dissolved in 
acetone was topically applied to the same ear 30 min 
before TPA, simultaneously with the pro-
inflammatory agent, or 60 and 180 min after TPA. The 
right ear received only acetone (vehicle control). Six 
hours after the final treatment, the mice were killed by 
cervical dislocation and plugs 6 mm in diameter from 
the central portion of both ears were taken and 
weighed. Extent of inflammation in a control group 
was determined as the difference in weights between 
the ear with TPA and the right ear with acetone, and 
edema reduction in the group of animals treated with 
the extract was expressed using the following 
equation:  
 
 
 
where ∆wc is the increase in ear weight in the control 
group and ∆wt is the increase in ear weight in animals 
treated with extract.   
 
Toxicological profile 
Animals were maintained under standard 
environmental conditions at a 12-h light/dark 
photoperiod. All animals were supplied with food and 
water ad libitum during the testing period. Acute 
toxicity was determined in male BALB-c mice (BW, 
22  2.2 g) and in Sprague Dawley rats (BW, 220  
22.0 g) following the methodology previously 
described by Lorke (Lorke, 1983). The rodents were 
randomly divided into groups of three animals each. 
Daily doses of the extract (140-1,000 mg/kg) 
solubilized in H2O:Tween 80 (9:1) were injected i.p to 
rats and daily doses of 140-5,000 mg/kg were injected 
into mice; a dose-dependent toxicity increase was 
determined in both animal species. Mortality was 
recorded within 15 days, and the 50% Lethal dose 
(LD50) was calculated as the geometric mean by 
Probit. At the end of the study, the internal organs 
(lung, kidney, heart, spleen, and liver) were extracted 
and a gross pathological observation was performed.  
Subacute toxicity was determined following 
the methodology previously described by OECD 
TG407 (OEDC, 2001). Sprague Dawley rats (BW, 220 
± 22.0 g) were randomly assigned to five groups with 
eight animals per group. Daily doses of 12, 25, and 50 
mg/kg extract were administered i.p. during 14 
consecutive days and two control groups (vehicle and 
saline solution) were included. General behavior was 
observed daily, and the weight of the animals was 
registered once a week. The animals that died during 
the test period were analyzed pathologically, and those 
that survived were examined at the end of the 
experimentation phase. On day 14, the rats were fasted 
overnight and were anesthetized with sodium 
pentobarbital (56 mg/kg) for blood collection from the 
cava vein. The biochemical parameters assessed 
utilizing Wiener Lab commercial kits were protein, 
alkaline phosphatase, glutamate oxaloacetate 
transaminase, glutamate pyruvate transaminase, 
gamma-glutamyl transferase, triglycerides, glucose, 
cholesterol, urea, and total bilirubin. Hematological 
profile included hemoglobin, leukocyte and platelet 
counts. Urine was collected for a general analysis with 
URITEST 10 strips. Hematological and chemistry 
analyses were performed employing automated 
equipment (Coulter T890 and Selectra II, 
respectively).  
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The rats were sacrificed by cervical 
dislocation and, after a macroscopic examination of 
liver, lungs, heart, kidneys and spleen, necropsy was 
performed soon after death. Tissue biopsies from the 
organs were fixed in 10% formalin, and processed, and 
embedded in paraffin. Paraffin slides were cut at 4-5 
µm with a rotary microtome and stained with 
hematoxylin and eosin. Samples were examined under 
light microscope with particular attention paid to 
organs that showed gross lesions. 
Following the methodology described in NOM 
MGA0515 by Draize (Draize, 1959), the dorsal region 
of 24 New Zealand white rabbits (BW, 3.5 kg) was 
carefully shaved 24 h before the study and groups of 
eight animals each were considered in this assay. The 
animals were housed individually in stainless-steel 
cages and maintained on a 12 h dark/12 h light cycle. 
The day of the experiment, two areas of 4 cm
2 
were 
delimited in the right dorsal region as well as in the 
left one, and one of these in each region was shaved 
again. The extract blended into vaseline in doses of 
100 or 280 mg/patch was topically applied to all four 
areas, covering these with patches. The presence of 
erythema or edema was examined 24 and 72 h after 
extract application. A negative control group without 
the extract was included.  
 
Statistical analysis 
Differences between treated animals and those of the 
control group were evaluated statistically with the 
Student t test, with p < 0.05 considered significant. 
Results in toxicological studies were expressed as 
mean ± Standard error of the mean (SEM) and the 
statistical significance between the groups was 
analyzed by means of a one-way Analysis of variance 
ANOVA (ANOVA) coupled
 
with the Student-
Newman-Keuls test with p < 0.05
 
as the minimum 
requirement for a statistically significant difference.
 
 
 
Bio-guided fractionation 
Mouse ear edema induced with a single dose of TPA 
(acute inflammation model) was employed as the 
biological test to monitor the activity of the CH2Cl2 
extract and the fractions. The extract (11 g) was 
chromatographed in a glass column (900 × 45 mm) 
packed with silica gel (320 g; 0.063–0.200 mm; 
Merck, Darmstadt) and eluted with organic solvents of 
increasing polarity. A total of 179 fractions of 250 mL 
each were collected and combined according to their 
Thin layer chromatography (TLC) profiles. Elutes 
were analyzed by TLC with mixtures of 
hexane:AcOEt (7:3) and spots were visualized with 
Ultraviolet (UV) 240/340 nm and by spraying with 
10% H2SO4, followed by heating the plates at 110° C. 
Active fractions F7 (CH2Cl2 100%) and F9 
(CH2Cl2:MeOH 9:1) were the most abundant (2.50 and 
6.57 g, respectively). Fraction F7 (1 g) was further 
fractionated in a 30 g silica gel column (600 × 15 mm) 
to obtain active fractions F7–5 (hexane:CH2Cl2 6:4) 
and F7–8 (hexane:CH2Cl2 1:1). A mixture of - and -
amyrins (40 mg) was precipitated from F7–5 and a 
mixture of stigmasterol and -sitosterol (30 mg) was 
precipitated from F7-8. The compounds were 
identified by Gas chromatography-Mass spectroscopy 
(GC-MS) analysis and comparative TLC with 
authentic samples. Further, F9 (3 g) was subjected to 
silica gel (50 g) column chromatography (600 × 25 
mm) with a gradient of hexane, CHCl3, and MeOH to 
yield 576 mg of the active fraction F9–8 
(CHCl3:MeOH 9:1). Fraction F9–8 was separated by 
preparative TLC to isolate scopoletin, a 
hydroxycoumarin that was identified by comparing 
GC-MS data with those reported in the literature 
(Murray et al., 1982). GC-MS spectra were obtained 
in a Hewlett Packard model 5890 series II gas 
chromatography interfaced with a JEOL JMS 
AX50HA mass spectrometer at 70 eV with a GC 
column HP-5MS (30 m - 0.25 mm i.d. and 250 m). 
The carried gas was He (Praxair) with 7 psi, 1 
mL/min. The temperature was programmed from 100–
300° C at the rate of 10° C × min; injection 
temperature was 260° C.  
Concentration of scopoletin in the extract was 
determined by High performance liquid 
chromatography (HPLC-UV) diode array detection 
(Waters). The samples were chromatographed in a 
reverse phase Spherisorb ODS2 column (Waters, 250 
× 4 mm; 5 µm) with a mobile phase of 0.01 M 
phosphoric acid (A) and methanol (B). Gradient 
elution was carried out; initial composition was 20% B 
and this increased to 80% B in 22 min, subsequently 
returning to initial composition in 6 min. The 
wavelength was set at 340 nm to detect scopoletin 
(Retention time [Rt] = 15.8 min). Scopoletin was 
detected by comparison of Rt and UV spectra with 
those of a certificated reference compound provided 
by the Institute of Chemical Metrology, Chile 
Foundation. A negligible signal of transcinnamic acid 
was also detected (Rt = 22.9 min) and was identified 
by comparison of RT with a commercial sample 
(Sigma). 
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RESULTS 
The Effect of the CH2Cl2 Extract in Chronic 
Inflammation Models 
Daily doses of 100 mg/kg extract administered i.p. for 
8 consecutive days, initiating administration 60 min 
prior to the CFA challenge, produced significant 
inhibition of edema only in the first 2 days (42.90 and 
49.37%, respectively); afterward, edema formation 
was the same as that determined in the control group 
(Table 1). 
 
 
 
Table 1 
Effect of the dichloromethane (CH2Cl2) extract in the onset of the chronic inflammation response 
 
 
Time (days) 
        Increase in paw volume (mL) 
Control Group Treatment Group % Inhibition 
     0 1.36 ± 0.04 1.30 ± 0.02 0 
1 3.06 ± 0.10     2.27 ± 0.17* 42.94 
2 2.94 ± 0.18     2.10 ± 0.07* 49.37 
3 2.24 ± 0.08 1.99 ± 0.07 21.59 
6 2.48 ± 0.08 2.38 ± 0.07   3.57 
8 2.25 ± 0.10 2.13 ± 0.07   6.74 
Doses of the extract (100 mg/kg × 8 days, intraperitoneally [i.p.]) administered starting on the day of the Complete 
Freund’s adjuvant (CFA) challenge. The vehicle was H20:Tween20, 9:1. Values are means ± Standard error of the 
mean (SEM) (n = 8). *P < 0.05. 
 
 
 
 
Phenylbutazone (100 mg/kg) demonstrated a 
similar profile, although with lower activity (ca. 20% 
during the first 48 h) (data not shown). In the chronic 
phase of the process, administration of the extract 
beginning 12 days after CFA injection caused 
sustained decrease of the edema, ranging from 40.2–
50.1% after three doses of the extract had been 
administered. The percentage of inhibition of edema 
was 62.6%, even 24 h after the last treatment (Table 
2). In this same experimental model, oral 
administration of 1 g/kg of the plant extract failed to 
reduce the formation of edema (data not shown). BW 
of the normal rats increased 40-50% at the end of the 
study; in contrast, an increase of 10.8% was registered 
in animals treated with CFA and a 22.43% increase in 
those receiving the extract (data not shown). 
In the chronic topical inflammation model 
induced with multiple applications of TPA, the extract 
maintained an anti-edematous effect (50.6%) even 
when the extract was applied 180 min after each TPA 
treatment (Table 3). As shown in this table, a dose of 
extract of 2 mg/ear applied 30 min prior to treatment 
with TPA reduced the induced edematous effect in 
41.1%.
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Table 2 
Effect of the dichloromethane (CH2Cl2) extract in the declared chronic inflammation response 
 
 
Time (days) 
            Increase in paw volume (mL) 
Control Group Treatment Group  % Inhibition 
0 2.14 ± 0.07 1.85 ± 0.08 0 
12 3.19 ± 0.20 3.04 ± 0.09 NE 
13 3.05 ± 0.12 2.77 ± 0.15 NE 
14 3.11 ± 0.13 2.43 ± 0.07* 40.2 
15 3.25 ± 0.10 2.47 ± 0.07* 44.1 
16 3.74 ± 0.16 2.66 ± 0.06* 49.4 
   19  3.73 ± 0.22 2.58 ± 0.06* 50.1 
20 4.09 ± 0.21 2.58 ± 0.05* 62.6 
Doses of the extract (100 mg/kg x 8 days; i.p.); intraperitoneally [i.p] administered starting on day 12 of 
the Complete Freund´s adjuvant (CFA) challenge. The vehicle in control group was H20:Tween 20, 9:1. 
Values are means ±Standard error of the mean (SEM) (n=8), * P < 0.05 and % inhibition. NE = no effect;  
 Last extract administration. 
 
 
Table 3 
Effect of the dichloromethane (CH2Cl2)  extract on dermal inflammation in mouse ear 
 
Extract application Ear edema (mg) % Inhibition 
Control (vehicle) 
30 min before TPA 
13.10 ± 0.10 
7.06 ± 0.31* 
0 
41.1 
Simultaneously with TPA 4.92 ± 0.85* 64.5 
60 min after TPA 5.56 ± 0.71* 51.3 
180 min after TPA 5.06 ± 0.53* 50.6 
Doses of the extract (2 mg/ear x five application) were topically applied: 1) 30 min before TPA, 2) 
simultaneously with TPA, or 3) 60 and 180 min after the extract. The vehicle was acetone. Values are 
means ± Standard error of the mean (SEM) (n = 8), * P < 0.05. 
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Toxicity of the Extract 
Using the abbreviated procedure of Lorke, the acute 
toxicity LD50 index for the crude extract was estimated 
as 350 mg/kg (i.p.) in rats and as 2150 mg/kg (i.p.) in 
mice. A non significant decrease in BW was 
determined in all of the treated groups.  
The sub-acute toxicity test in rats showed that 
i.p. administration of the CH2Cl2 extract was well 
tolerated by the animals, and daily doses of 12.5-50 
mg/kg for 14 consecutive days did not produce 
mortality. In comparison with the controls, no 
significant differences in BW gain throughout the 
treatment period were determined.  
In rats treated with 50 mg/kg of the extract, 
serum triglyceride levels increased 32.4% but High 
density lipoprotein concentration (HDL) was 23.8% 
lower than that in the control group. Likewise, a slight 
increase in the relative weight of the spleen was 
detected with the higher dose of the 50 mg/kg extract, 
whereas no significant differences
 
were determined for 
the remainder of the organs evaluated. On the other 
hand, generalized, dose-dependant fibro-adhesive 
peritonitis occurred in the animals injected with the 
extract and evident treatment-related changes were 
identified in the liver of the rats at all dose levels.  
Steatosis was detected in animals receiving 50 
mg/kg of the extract. However, administration of the 
previously filtrated extract through Filtropur S 0.2-20 
µm filters did not produce significant changes in 
hematological parameters. Similarly, the filtrated 
extract did not produce noticeable alterations in the 
liver compared with the control group, exhibiting 
normal parenchymal architecture with cords of 
hepatocytes and portal tracts. No further evidence of 
histopathological changes could be attributed to the 
extract and the biological evaluation of the filtrated 
product showed preserved activity of the original 
extract. In conclusion, no sign of irritation was 
attributed to the extract in dermal test carried out in 
rabbits.  
 
Bio-guided Chemical fractionation of the extract 
A single dose of 2.5 g/ear TPA in mouse induced an 
edematogenic response that was evidenced by a 
significant increase in ear weight. The higher dose (2 
mg/ear) was employed to test the crude extract and the 
primary fractions, while smaller doses were used to 
evaluate the second fractions and the pure compounds.  
Topical application of 2 mg/ear crude extract 30 min 
after TPA reduced edema formation by 73.1%, an 
effect near that determined with the same dose of 
indomethacine (75%). The two major active fractions, 
F7 and F9, inhibited edema by 55.1 and 70.6%, 
respectively. On the other hand, subfraction F7-8 at a 
lower dose of 0.5 mg/ear significantly increased anti-
edematous activity to 73.2%; this effect was higher 
than that determined with the mixture of identified 
compounds in F7 (a mixture of - and -amyrin and 
-sitosterol) at the same dose. In this model, no effect 
was observed with pure isolated stigmasterol (Table 
4). On the other hand, at a dose of 1 mg/ear, inhibitory 
activity of subfraction F9–8 was 55.3% and isolated 
scopoletin from this fraction inhibited 54.2%, 
approximating the effect obtained with a commercial 
sample of scopoletin (52.2%). 
The content of scopoletin in the extract 
determined by HPLC with the certificated reference 
was 0.5 mg/g. Determined IC50 values were 0.37, 0.48, 
and 0.88 mg/ear for the extract, scopoletin, and -
sitosterol, respectively, higher than that of 
indomethacine (IC50 = 0.10 mg/ear).  
 
DISCUSSION 
The effect produced by the i.p. administration of 
repeated doses of S. angustifolia CH2Cl2 extract was 
evaluated in the chronic inflammatory response 
induced with CFA in rat, and two strategies were 
designed for this purpose. Administration of the 
extract immediately prior to injection of the adjuvant 
and repeating the treatment for 8 consecutive days 
produced a significant reduction of edema formation 
only in the early stage of the inflammatory response 
(during the first 48 h). Conversely, once the chronic 
phase of inflammation was already triggered (12 days 
after the CFA challenge), daily administration of the 
extract produced from the second dose onward, 
sustained and significant inhibition of edema, the 
effect persisting even 24 h after the last treatment. The 
results obtained are in accordance to a parallel study 
performed that demonstrated that in the CFA model, 
IL-1 , IL-6, TNF- , and IL-10 have maximum 
expression in the late phase of the inflammatory 
response and that the S. angustifolia extract produce 
significant inhibition of proinflammatory IL-1 , IL-6, 
and TNF- , but increased anti-inflammatory IL-10 
levels (Juárez-Ciriaco et al., 2008). Although a 
significant anti-inflammatory effect of the extract was 
established when administered i.p., oral administration 
of this plant product lacked its inhibitory activity, even 
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at a high dose of 1 g/kg daily administered for 10 days. 
This observation allows the assumption that oral use of 
the plant as a decoction to treat intestinal disorders 
might be related with other compounds that are not 
present in the dichloromethane extract. The anti-
inflammatory effect of the S angustifolia reported by 
Meckes et al., 2004 in the acute inflammation model 
with carrageenan in rats, in addition to that observed in 
this work, permit us to know, in part, the therapeutic 
potential of this plant. 
 
 
Table 4  
Activities of the dichloromethane (CH2Cl2) extract, fractions and pure compounds in mouse ear edema model 
 
Sample Dose 
(mg/ear) 
  Mouse ear edema (mg)    
     Control                   Treated      
Inhibition (%) 
CH2Cl2 extract 2 13.21 ± 0.44   3.55 ± 0.42 73.1 
F7 2   7.81 ± 0.68   3.50 ± 0.32 55.1 
F7-5 1   7.90 ± 0.84   5.73 ± 0.83 27.5 
* -+ - amyrin 0.5 11.03 ± 0.75   5.30 ± 0.85 52.0 
F7-8 0.5   9.97 ± 0.10   2.67 ± 0.24 73.2 
*  Sitosterol+Stigmasterol 0.5 12.12 ± 0.87   9.47 ± 0.28 21.9 
F9 2 8.93 ± 0.81 2.63 ± 0.65 70.6 
F9-8 1 12.87 ± 0.30   5.75 ± 0.34 55.3 
Scopoletin (isolated) 1 11.32 ± 0.34 5.18 ± 0.60 54.2 
COMMERCIAL REFERENCES      
    Scopoletin 1 11.98 ± 0.14 5.73 ± 0.22 52.2 
    -sitosterol 0.5 12.75 ± 0.51   6.70 ± 0.97 47.5 
    Stigmasterol 0.5 11.57 ± 0.16 11.84 ± 0.58 NE 
    Indomethacine  0.5 11.04  0.69   2.76  0.52 75.0 
The samples were tested in the acute mouse ear edema model (single dose of TPA). NE= no effect.  * Mixture of compounds in 
the fraction. Values are means ± Standard error of the mean (SEM) (n = 6). 
 
In addition to the demonstrated anti-
inflammatory effect of the extract on the adjuvant-
induced arthritis model, topical application of the 
extract suppressed ear edema in mouse. It has been 
established that multiple cutaneous applications of 
TPA to mouse ear produce a prolonged inflammatory 
reaction characterized by edema formation, 
inflammatory cell infiltration, and epidermal 
hyperplasia (Stanley et al., 1991). In this model, the 
extract exhibited both strong anti-inflammatory action 
and a protective effect against the irritant. Chemical 
study of the plant extract produced active fractions 
containing -sitosterol, stigmasterol, - and -
amyrins, transcinnamic acid, and scopoletin. The latter 
was the main constituent found in the more active 
fraction of the extract, its anti-edematous effect in the 
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ear inflammation model was nearly comparable with 
that of the whole fraction. Scopoletin has been isolated 
from several plant species and, recently, new 
information related with its anti-arthritic properties has 
appeared in the scientific literature (Pan et al., 2009; 
Pan et al., 2010). It was reported that when injected 
i.p. in adjuvant-induced arthritic rats at doses > 100 
mg/kg of the compound, the latter produced nearly 
normal histological architecture of the joints, 
downregulate the overexpression of Vascular 
endothelial growth factor, basic Fibroblast growth 
factor (bFGF), and IL-6 in the synovial tissues. In 
short, it reduces the numbers of new blood vessels in 
the synovium and the production of important 
endogenous angiogenic inducers (Pan et al., 2009).  
It is well known that cytokines such as IL-1, 
TNF- , and IL-6 are also proinflammatory in vitro and 
scopoletin was able to inhibit these cytokines in 
Lipopolysaccharide (LPS)-stimulated mouse leukemic 
monocyte macrophage cell line (RAW) 264.7; in 
addition, scopoletin inhibited the production of 
Prostaglandin E2 (PGE2) and Cyclooxygenase-2 
(COX-2) (Meckes et al., 2004). 
As shown in Table 3, the subfraction F7-8 has 
a good activity at a dose of 0.5 mg/ear (73% 
inhibition) and it probably contains, besides β-
sitosterol, any other compound which was not detected 
in this study. We assume that it is a compound that 
acts in interaction with the phytosterol whose activity 
is around 47.5%; unfortunately, the amount of F7-8 
obtained was low and the compound was not 
identified.  
The toxicological studies available on i.p. 
administration of the extract did not indicate a severe 
systemic toxicity, adverse reactions, or hematological 
and biochemical alterations when the extract is 
previously filtered. Histopathologic examination 
performed on select tissues from the control and the 
high-dose group indicated no treatment-related 
changes considered to be of toxicological significance.  
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CONCLUSION  
In an experimental arthritis model, the S. angustifolia 
dichloromethane extract exerts a significant anti-
edematous effect on the CFA-induced chronic 
inflammation phase, results that could be associated 
with the previously reported inhibition of IL-1 , IL-6, 
and TNF- . In addition, topical application of the 
extract produces strong anti-inflammatory action and a 
protective effect against TPA mouse ear irritation. 
Active fractions contain -sitosterol, stigmasterol, - 
and -amyrins, transcinnamic acid, and scopoletin, 
with scopoletin the main constituent found in the 
extract´s more active fraction. The anti-edematous 
effect in the ear inflammation model was nearly 
comparable with that of the whole fraction. No 
treatment-related changes were considered to possess 
toxicological significance when the extract was 
previously sterilized by filtration.   
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